You have 9 free searches left this month | for more free features.

cisplatin

Showing 51 - 75 of 1,923

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

Recruiting
  • Untreated Resectable Pancreatic Adenocarcinoma
  • +2 more
  • Paclitaxel protein bound
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
May 10, 2022

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • (no location specified)
Apr 24, 2023

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

Completed
  • Hypopharynx Squamous Cell Carcinoma
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +5 more
Nov 9, 2022

Urothelial Carcinoma, Locally Advanced, Unresectable Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urothelial Carcinoma
  • +2 more
  • Chicago, Illinois
  • +8 more
Dec 23, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Urothelial Carcinoma Trial in United States (Gemcitabine, Cisplatin, Ipilimumab)

Completed
  • Urothelial Carcinoma
  • Duarte, California
  • +7 more
Jul 7, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

Recruiting
  • SCCHN
  • Squamous Cell Carcinoma
  • Cisplatin
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)

Recruiting
  • Adenocarcinoma
  • +9 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 15, 2022

Bladder Cancer, Metastatic Bladder Cancer, Urothelial Carcinoma Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Hartford, Connecticut
  • +10 more
Nov 23, 2022

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Diffuse Large B-cell Lymphoma Trial in Chapel Hill (Polatuzumab vedotin (PV), Rituximab, Hyaluronidase)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Polatuzumab vedotin (PV)
  • +6 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Aug 9, 2022

Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • San Antonio, Texas
    Mays Cancer Center
Mar 11, 2022

Head and Neck Squamous Cell Carcinoma Trial in Tours (Docetaxel, Cisplatin, Fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tours, France
    Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan
Mar 10, 2022

Esophageal Squamous Cell Carcinoma Trial in Beijing (nab-paclitaxel, Cisplatin, Capecitabine)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 13, 2022

Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting
  • Resectable Cholangiocarcinoma
  • +5 more
  • Cisplatin
  • +2 more
  • Atlanta, Georgia
  • +6 more
Oct 5, 2022

Cervical Cancer Trial in Providence (Nivolumab induction, Cisplatin, Radiation)

Terminated
  • Cervical Cancer
  • Nivolumab induction
  • +4 more
  • Providence, Rhode Island
  • +1 more
Mar 30, 2022

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • Duarte, California
  • +6 more
Jul 7, 2022

Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +21 more
Aug 16, 2022

Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma of the Urinary Bladder
  • New York, New York
    Columbia University Medical Center- HIP
Feb 3, 2022

Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

Recruiting
  • Locally Recurrent/Metastatic Triple Negative Breast Cancer
  • external beam radiation therapy
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022